Join Free
SI Premium
RSS Feeds
E-mail Alerts
Portfolio
Login
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
AbbVie
(NY:
ABBV
)
178.49
+0.61 (+0.34%)
Official Closing Price
Updated: 7:00 PM EDT, Mar 18, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
8,617,194
Open
179.01
Bid (Size)
178.05 (2)
Ask (Size)
178.49 (3)
Prev. Close
177.88
Today's Range
177.56 - 179.88
52wk Range
130.96 - 182.89
Shares Outstanding
N/A
Dividend Yield
3.32%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
10 Health Care Stocks Whale Activity In Today's Session
Today 13:35 EDT
Via
Benzinga
Here's How Much $100 Invested In AbbVie 10 Years Ago Would Be Worth Today
Today 11:30 EDT
Via
Benzinga
Performance
YTD
+11.68%
+11.68%
1 Month
+1.56%
+1.56%
3 Month
+16.34%
+16.34%
6 Month
+15.95%
+15.95%
1 Year
+14.33%
+14.33%
More News
Read More
2 Top Dividend Stocks to Buy Hand Over Fist
March 17, 2024
Via
The Motley Fool
Decoding AbbVie's Options Activity: What's the Big Picture?
March 14, 2024
Via
Benzinga
How Much a $1 Million Portfolio Would Pay in Dividends
March 13, 2024
Via
The Motley Fool
SCHD ETF Spotlight: The Top 6 Stocks Inside This Dividend Monster
March 13, 2024
Via
InvestorPlace
Topics
ETFs
Is AbbVie Stock a Buy Now?
February 29, 2024
Via
The Motley Fool
3 Must-Have Dividend Kings for a Steady Income Stream
March 12, 2024
Via
InvestorPlace
Trouble-Proof Dividend Darlings: 7 Stocks That Keep Paying No Matter What
March 11, 2024
Via
InvestorPlace
Topics
Economy
Exposures
Economy
MoonLake Jumps After Arthritis Drug Tops AbbVie Blockbuster Humira In A Key Test
March 11, 2024
Via
Investor's Business Daily
Why Is Inflammatory Disease-Focused MoonLake Immunotherapeutics Stock Trading Higher Today?
March 11, 2024
Via
Benzinga
3 Pharmaceutical Stocks to Buy Hand Over Fist in March
March 11, 2024
Via
The Motley Fool
3 Unstoppable Mega-Cap Stocks That Every Investor Should Own in 2024
March 09, 2024
Via
InvestorPlace
The AI Race Gets Litigious
March 09, 2024
Via
The Motley Fool
Topics
Artificial Intelligence
Intellectual Property
Exposures
Artificial Intelligence
Intellectual Property
Have $2,500? 2 Superior Growth Stocks to Buy in 2024
March 09, 2024
Via
The Motley Fool
FDA Conditionally Approves Expanded Use Of BeiGene's Combination Drug For Certain Type Of Blood Cancer
March 08, 2024
Via
Benzinga
Exposures
Product Safety
3 Dividend Aristocrats With the Largest 10-Year Dividend Growth Rates
March 06, 2024
Via
InvestorPlace
10 Health Care Stocks Whale Activity In Today's Session
March 06, 2024
Via
Benzinga
The Top 7 Dividend Stocks to Buy in March 2024
March 06, 2024
Via
InvestorPlace
Increasing Incidence of Pancreatic Cancer Leading to a $6.85 Billion Dollar Market Size for New Treatments
March 05, 2024
Via
FinancialNewsMedia
Increasing Incidence of Pancreatic Cancer Leading to a $6.85 Billion Dollar Market Size for New Treatments
March 05, 2024
From
FN Media Group LLC
Via
GlobeNewswire
Secure Your Future: 7 Dividend Kings with Solid Growth Potential
March 04, 2024
Via
InvestorPlace
Wall Street's Most Accurate Analysts' Views On 3 Health Care Stocks Delivering High-Dividend Yields
March 01, 2024
Via
Benzinga
The Hot List: 3 AI Stocks Worth Buying on Weakness
March 01, 2024
Via
InvestorPlace
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Better Dividend Growth Stock: AbbVie or Amgen?
February 29, 2024
Via
The Motley Fool
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.